Canal-U

Mon compte

Résultats de recherche

Nombre de programmes trouvés : 496
Conférences

le (58m17s)

Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 5 : Will we be able to answer the question of HDL as a therapeutic target after the CETP inhibitor trials? (Robert ROSENSON)

... Thus, the question arises, whether these additional compounds will lead to a clinically significant reduction in cardiovascular events on top of optimal standard care.Trials (Interventions)➢ CETP inhibitors: dalcetrapib, anacetrapib, evacetrapib...
Voir la vidéo

 
FMSH
 
Facebook Twitter
Mon Compte